TBK1 as a key regulator in breast cancer: opportunities for targeted therapy
Breast Cancer · 13.11.2026
DOI: 10.1007/s12282-026-01928-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Breast Cancer, online erschienen am 13.11.2026. Verfasst von Helal F Hetta und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of T…. Die Arbeit nennt 124 Literaturangaben.
Abstract (Originalsprache)
TANK-binding kinase 1 (TBK1) is a serine/threonine kinase that plays a critical role in innate immunity, inflammation, and cellular responses to stress. Recent studies have highlighted the pleiotropic roles of TBK1 in cancer. It has been shown to coordinate processes such as inflammation, autophagy, cell cycle progression, and cell death. TBK1 overexpression, aberrant kinase activation (pSer172), and cancer cell functional dependency have each been linked to tumorigenesis, metastasis, and therapeutic resistance. TBK1 is structurally organized into specific domains that are implicated in the mechanisms of its activation and the engagement of different adaptor proteins, dictating its subcellular location and function in different contexts. Phosphorylation, together with ubiquitination, are prominent post-translational modifications that govern TBK1 activity and contribute to several nodes of therapeutic intervention. Within breast cancer, TBK1 modulates both tumor-intrinsic pathways and tumor-extrinsic pathways, regulating not only cancer cell survival and proliferation but also the tumor microenvironment. Preclinical data indicate that inhibition of TBK1 could inhibit tumor growth and sensitize tumors to traditional and immune-based therapies. Nevertheless, the intricate regulation of TBK1 and context-dependent functions demonstrate the requirement for subtle therapeutic interventions, possibly involving combinatorial therapies. In this review, we summarize current literature about TBK1's structural features, regulation, and activities in breast cancer; review the rapidly growing evidence implicating TBK1 as a target for therapy; and consider ways of translating these insights into clinical practice in the future. Deciphering how TBK1 exerts distinct roles will open up new opportunities for targeted therapy for breast cancer and possibly other cancers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Microbiology, Immunology and Biotechnology, Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, 71491, Tabuk, Saudi Arabia. hhussen@ut.edu.sa.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, 71491, Tabuk, Saudi Arabia.
- Department of Diagnostic Radiology, Faculty of Medicine, University of Tabuk, 71491, Tabuk, Saudi Arabia.
- Department of Family and Community Medicine, Faculty of Medicine, University of Tabuk, 47512, Tabuk, Saudi Arabia.
- Department of Experimental Medicine, King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Ministry of National Guard-Health Affairs (MNGHA), Riy…
- Forensic Toxicology Services, Forensic Medical Services Center, Ministry of Health, Abha, Saudi Arabia.
Zitieren
APA
Hetta, H. F., Alanazi, F. E., Bukhari, S. Q., Alatawi, Z., Abdullah, M. L., Alfardan, A. S., Al-Hamamah, M. A., Alshahrani, F. A., Alatawi, F. O., AlRamadneh, T. N., Abd Ellah, N. H., Ramadan, Y. N., & Kotb, A. A. (2026). TBK1 as a key regulator in breast cancer: opportunities for targeted therapy. Breast Cancer. https://doi.org/10.1007/s12282-026-01928-2
Vancouver
Hetta HF, Alanazi FE, Bukhari SQ, Alatawi Z, Abdullah ML, Alfardan AS, et al. TBK1 as a key regulator in breast cancer: opportunities for targeted therapy. Breast Cancer. 2026. doi:10.1007/s12282-026-01928-2
BibTeX
@article{Hetta2026,
author = {Hetta, Helal F and Alanazi, Fawaz E and Bukhari, Salwa Qasim and Alatawi, Zinab and Abdullah, Mashan L and Alfardan, Ali S and Al-Hamamah, Mohammed A and Alshahrani, Fahad Abdullah and Alatawi, Fahad O and AlRamadneh, Tareq Nayef and Abd Ellah, Noura H and Ramadan, Yasmin N and Kotb, Ahmed A},
title = {TBK1 as a key regulator in breast cancer: opportunities for targeted therapy},
journal = {Breast Cancer},
year = {2026},
doi = {10.1007/s12282-026-01928-2}
}
EUVIMED